SCHEMBL3206019

SCHEMBL3206019

CN(C)c1ccc2c(OS(=O)(=O)C(F)(F)F)cc(=O)oc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 2/20 0.41
ALDH1A1 P00352 7/20 0.41
IGLV6-57 P01721 6/20 0.41
HPGD P15428 5/20 0.41
HSD17B10 Q99714 3/20 0.41
GLA P06280 2/20 0.41
CYP3A4 P08684 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
MAPK1 P28482 2/20 0.41
CASP1 P29466 2/20 0.41
CASP7 P55210 2/20 0.41
ATM Q13315 2/20 0.41
HIF1A Q16665 1/20 0.41
KDM4E B2RXH2 5/20 0.40
MAPT P10636 3/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
TDP1 Q9NUW8 3/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31710846 0.83 CA2 (0.43) ARALDH1A1HPGDKDM4EMEN1
SCHEMBL759113 0.83 CA2 (0.43) ARALDH1A1HPGDKDM4EMEN1
SCHEMBL2987667 0.82 AR (0.40) ARALDH1A1HPGDHSD17B10GLA
SCHEMBL764738 0.81 CA2 (0.39) ARALDH1A1HPGDHSD17B10GLA
SCHEMBL30231652 0.81 KDM4E (0.55) ARALDH1A1HPGDHSD17B10GLA
SCHEMBL3553197 0.81 KDM4E (0.55) ARALDH1A1HPGDHSD17B10GLA
SCHEMBL3544562 0.81 AR (0.41) ARCA2CA1CA5ACA9
SCHEMBL757973 0.81 AR (0.41) ARALDH1A1HPGDHSD17B10CASP1
SCHEMBL12986005 0.79 KCNA3 (0.51) ALDH1A1L3MBTL1MEN1KMT2ACA1
Hydrogen Sulfide SCHEMBL6879015 0.76 KDM4E (0.55) ARALDH1A1HPGDHSD17B10GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100048604-A1 Ligands for Aldoketoreductases TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2010-02-25 US disclosed
US-20100048604-A1 Ligands for Aldoketoreductases TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2010-02-25 US disclosed
US-20100048604-A1 Ligands for Aldoketoreductases TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2010-02-25 US disclosed
WO-2006023821-A2 LIGANDS FOR ALDOKETOREDUCTASES THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2006-03-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048604-A1 Ligands for Aldoketoreductases AKR1C2, AKR1C1, AKR1B1 AR 182/4885ALDH1A1 18/4885IGLV6-57 4615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.